Related Experiment Video
Updated: Mar 22, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Adenoviral vector-based strategies against infectious disease and cancer
1a Vaccine Research Center, Key Laboratory of Molecular Virology & Immunology, Institute Pasteur of Shanghai, Chinese Academy of Sciences , Shanghai , China.
Abstract:
Adenoviral vectors are widely employed against infectious diseases or cancers, as they can elicit specific antibody responses and T cell responses when they are armed with foreign genes as vaccine carriers, and induce apoptosis of the cancer cells when they are genetically modified for cancer therapy. In this review, we summarize the biological characteristics of adenovirus (Ad) and the latest development of Ad vector-based strategies for the prevention and control of emerging infectious diseases or cancers. Strategies to circumvent the pre-existing neutralizing antibodies which dampen the immunogenicity of Ad-based vaccines are also discussed.
Insights
Adenoviral vectors are powerful tools for vaccines and cancer therapy. This review covers their characteristics, applications, and strategies to overcome immune barriers for improved efficacy.
Area of Science:
- Virology
- Immunology
- Biotechnology
Background:
- Adenoviruses (Ads) are versatile viral vectors utilized in medicine.
- They serve as vaccine carriers eliciting immune responses and as agents for cancer therapy inducing apoptosis.
- Pre-existing neutralizing antibodies can limit the effectiveness of Ad-based strategies.
Purpose of the Study:
- To review the biological characteristics of adenoviruses.
- To summarize the latest developments in Ad vector-based strategies for infectious diseases and cancers.
- To discuss methods for overcoming pre-existing neutralizing antibodies against Ad vectors.
Main Methods:
- Literature review of adenoviral vector applications.
- Analysis of strategies for enhancing Ad vector immunogenicity.
- Discussion of Ad vector-based vaccine and cancer therapy approaches.
Main Results:
- Adenoviral vectors are effective in eliciting antibody and T cell responses for vaccines.
- Genetically modified adenoviral vectors can induce cancer cell apoptosis for therapy.
- Strategies exist to mitigate the impact of pre-existing neutralizing antibodies.
Conclusions:
- Adenoviral vectors hold significant promise for combating emerging infectious diseases and cancers.
- Further research into overcoming immune limitations will enhance their therapeutic and prophylactic potential.
- Ad vector technology is a rapidly advancing field with broad applications in medicine.
More Related Videos
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Inhibitors of Viral Protein Synthesis

